MAY - 2023$15www.pharmatechoutlook.comISSN 2644-2787LEADING THE WAY WITH IN VIVO PHENOTYPIC SCREENING AND DRUG REPOSITIONINGCONTRACT RESEARCH ORGANIZATIONAndrew Reaume, President and CEOMelior Discovery
Page 2 >